VolitionRx Limited to Present COVID-19 Data at MEDICA 2020
Nov 12, 20209:15 PM
VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update
Nov 10, 20201:15 PM
Volition Veterinary Presents Expert Report Ahead of First Product Launch
Nov 09, 20201:15 PM
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
Oct 21, 20201:15 PM
VolitionRx Limited Releases Video of Virtual Capital Markets Day 2020
Oct 16, 20201:15 PM
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference
Oct 14, 20201:15 PM
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
Oct 12, 20201:15 PM
Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference
Sep 29, 20201:15 PM
VolitionRx Limited Announces Virtual Capital Markets Day 2020
Sep 01, 20201:15 PM
VolitionRx Limited to Present at Conferences in September 2020
Aug 13, 20209:15 PM
VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update
Aug 10, 202012:45 PM
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
Jul 14, 202011:15 AM
Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
Jun 25, 20202:00 PM
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
May 27, 20202:00 PM
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
May 22, 20209:15 PM
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
May 20, 20202:00 PM
VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
May 13, 202010:15 PM
VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
May 07, 20209:15 PM
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
May 05, 20201:45 PM
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update
Apr 29, 20201:45 PM
Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers
Apr 23, 20201:45 PM
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies
Mar 10, 20201:00 PM
VolitionRx Limited Releases Annual Corporate Brochure and Video
Mar 03, 20201:45 PM
VolitionRx Limited to Present at Conferences in March 2020
Feb 20, 20209:15 PM
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
Feb 18, 20209:15 PM
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
Feb 18, 20201:45 PM
Volition Unveils Its Epigenetic Toolbox
Feb 07, 202010:45 PM
VolitionRx Announces Filing of Registration Statements
Jan 13, 20202:15 PM
Volition Develops a New Improved Nu.Q™ Assay Format